Jump Financial, LLC Coherus Bio Sciences, Inc. Transaction History

Jump Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 21, 2024	BUY	$1.59 - $3.85 $17,776 - $43,043	11,180 Added 50.62%	33,267 $110,000
Q4 2023 Feb 07, 2024	BUY	$1.59 - $3.85 $17,776 - $43,043	11,180 Added 50.62%	33,267 $110,000
Q3 2023 Oct 21, 2024	SELL	$3.74 - $5.45 $278,252 - $405,474	-74,399 Reduced 77.11%	22,087 $82,000
Q3 2023 Nov 07, 2023	SELL	$3.74 - $5.45 $278,252 - $405,474	-74,399 Reduced 77.11%	22,087 $82,000
Q2 2023 Oct 21, 2024	BUY	$3.79 - $8.3 $312,902 - $685,248	82,560 Added 592.85%	96,486 $411,000
Q2 2023 Aug 07, 2023	BUY	$3.79 - $8.3 $312,902 - $685,248	82,560 Added 592.85%	96,486 $411,000
Q1 2023 Oct 21, 2024	BUY	$5.89 - $10.52 $82,024 - $146,501	13,926 New	13,926 $95,000
Q1 2023 May 03, 2023	BUY	$5.89 - $10.52 $82,024 - $146,501	13,926 New	13,926 $95,000
Q2 2022 Aug 09, 2022	BUY	$5.86 - $13.23 $280,113 - $632,407	47,801 New	47,801 $346,000
Q4 2021 Feb 10, 2022	SELL	$15.81 - $18.99 $270,777 - $325,241	-17,127 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$12.68 - $17.79 $85,881 - $120,491	-6,773 Reduced 28.34%	17,127 $275,000
Q2 2021 Aug 13, 2021	BUY	$12.95 - $15.41 $309,505 - $368,299	23,900 New	23,900 $331,000

135

77.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $122M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.